6676 logo

Sunny Pharmtech TPEX:6676 Stock Report

Last Price

NT$29.60

Market Cap

NT$4.4b

7D

1.7%

1Y

27.9%

Updated

27 Mar, 2024

Data

Company Financials

6676 Stock Overview

Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally.

6676 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Sunny Pharmtech Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sunny Pharmtech
Historical stock prices
Current Share PriceNT$29.60
52 Week HighNT$45.20
52 Week LowNT$22.35
Beta-0.055
1 Month Change-6.92%
3 Month Change-14.94%
1 Year Change27.86%
3 Year Changen/a
5 Year Changen/a
Change since IPO25.69%

Recent News & Updates

Recent updates

Shareholder Returns

6676TW PharmaceuticalsTW Market
7D1.7%1.7%1.1%
1Y27.9%5.9%26.7%

Return vs Industry: 6676 exceeded the TW Pharmaceuticals industry which returned 5.9% over the past year.

Return vs Market: 6676 exceeded the TW Market which returned 26.7% over the past year.

Price Volatility

Is 6676's price volatile compared to industry and market?
6676 volatility
6676 Average Weekly Movement4.5%
Pharmaceuticals Industry Average Movement3.9%
Market Average Movement4.2%
10% most volatile stocks in TW Market7.9%
10% least volatile stocks in TW Market1.9%

Stable Share Price: 6676 has not had significant price volatility in the past 3 months.

Volatility Over Time: 6676's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1994129Yon-Lian Wuhttps://www.sunnypharmtech.com

Sunny Pharmtech Inc. engages in the research, development, production, and sale of drug substances and products, and active pharmaceutical ingredients in Taiwan and internationally. Its products portfolio include lidocaine ointment that can be used as an anesthetic lubricant for intubation, which temporarily relieves pain associated with minor burns, sunburn, skin abrasions, and insect bites; cyanocobalamin injection for use in vitamin B12 deficiency and pernicious anemia caused by malabsorption; nitrofurantoin capsules for urinary tract infection; aminocaproic acid tablets for blood diseases, as well as for hyper-proteolytic enzymes; and carboprost tromethamine injection for therapeutic abortion and postpartum hemorrhage. The company was founded in 1994 and is based in Taoyuan, Taiwan.

Sunny Pharmtech Inc. Fundamentals Summary

How do Sunny Pharmtech's earnings and revenue compare to its market cap?
6676 fundamental statistics
Market capNT$4.40b
Earnings (TTM)-NT$115.98m
Revenue (TTM)NT$381.56m

11.5x

P/S Ratio

-37.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
6676 income statement (TTM)
RevenueNT$381.56m
Cost of RevenueNT$120.15m
Gross ProfitNT$261.41m
Other ExpensesNT$377.39m
Earnings-NT$115.98m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.78
Gross Margin68.51%
Net Profit Margin-30.40%
Debt/Equity Ratio59.6%

How did 6676 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.